Please login to the form below

Not currently logged in
Email:
Password:

Havas Health & You expands leadership team

Philippe Huot-Louradour joins as EU technology & innovation lead

Health and communications network Havas Health & You has appointed Philippe Hout-Louradour as European technology & innovation lead, with HH&Y West CEO also taking on the role of global chief digital officer. 

David HuntTogether, Huot-Louradour and Hunt (pictured left) will continue to drive the growing innovation agenda at the company to build bespoke teams and services customised to client needs. This continued expansion is in line with a growing demand for data and technology-based solutions in the health and wellness sector.

“We already have great digital capabilities within our individual European agencies. Philippe will be able to orchestrate that appropriately, while harnessing the greater technology capabilities of the Havas and Vivendi Groups, to drive best in class innovation that contributes to our global agenda,” said John Hackney, CEO of HH&Y Europe.Philippe Huit-Louradour

Huot-Louradour (pictured right) brings over 15 years of health and digital experience to his new role at HH&Y, having previously held the position of managing director at Havas digital agency Full Six, setting up Full Six Health. More recently, he served as managing director of Havas Health Paris.

“Our innovation practice globally is a key competitive advantage for us and will be an even deeper focus moving forward. The impact of technology and data as it relates to health and wellness cannot be understated, and David and Phillipe bring profound expertise to help drive our offering in the EU and around the globe,” said Donna Murphy, HH&Y global CEO.

Article by
Lucy Parsons

29th January 2020

From: Marketing

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...